Human Lung Macrophages Challenged to Oxidants ex vivo: Lysosomal Membrane Sensitization is Associated with Inflammation and Chronic Airflow Limitation
The lung macrophage (LM) is involved in most inflammatory processes of the human lung by clearance of dying cells and by wound repair. Upon cellular stress by oxidant challenge in vivo lysosomes may rupture in LMs and leakage of cellular content and cell debris may trigger airway inflammation and fi...
Saved in:
Published in | Journal of inflammation research Vol. 13; pp. 925 - 932 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
New Zealand
Dove Medical Press Limited
01.01.2020
Taylor & Francis Ltd Dove Dove Medical Press |
Subjects | |
Online Access | Get full text |
ISSN | 1178-7031 1178-7031 |
DOI | 10.2147/JIR.S280419 |
Cover
Abstract | The lung macrophage (LM) is involved in most inflammatory processes of the human lung by clearance of dying cells and by wound repair. Upon cellular stress by oxidant challenge in vivo lysosomes may rupture in LMs and leakage of cellular content and cell debris may trigger airway inflammation and fibrosis, which may lead to chronic airflow limitation (CAL).
The aim of this study was to determine whether lysosomal membrane permeabilization (LMP) in LMs challenged to oxidants ex vivo is associated with airway inflammation and CAL, the latter assessed as the reduced forced expiratory volume in one second (FEV
) expressed as % of predicted.
Twenty-eight subjects were investigated; 13 lung-healthy subjects and 15 subjects with a variety of inflammatory disorders, demonstrating CAL on dynamic spirometry (defined as an FEV
/FVC ratio < 0.70). LMs were harvested by broncho-alveolar lavage (BAL) and challenged ex vivo by oxidants. LMP in oxidant-exposed LMs was assessed as the emitted acridine orange (AO) green fluorescence from oxidant-exposed LMs (using macrophage-like murine J774 cells as positive controls). Inflammatory cells in BAL were counted and lung volumes were recorded.
Oxidant-induced LMP in LMs was significantly greater among subjects with CAL and particularly among those with ongoing inflammation. Previous tobacco history did not influence LMP. Among subjects with CAL, oxidant-induced LMP correlated negatively with FEV
% of predicted.
Lysosomes of LMs harvested from patients with CAL demonstrate an increased sensitivity to oxidants, which may trigger mechanisms behind CAL, eg, chronic airway inflammation and fibrotic re-modelling. The study suggests a mechanistic role for LMP in LMs on airway inflammation, suggesting an anti-inflammatory effect by drugs that prevent increased LMP. |
---|---|
AbstractList | The lung macrophage (LM) is involved in most inflammatory processes of the human lung by clearance of dying cells and by wound repair. Upon cellular stress by oxidant challenge in vivo lysosomes may rupture in LMs and leakage of cellular content and cell debris may trigger airway inflammation and fibrosis, which may lead to chronic airflow limitation (CAL).BACKGROUNDThe lung macrophage (LM) is involved in most inflammatory processes of the human lung by clearance of dying cells and by wound repair. Upon cellular stress by oxidant challenge in vivo lysosomes may rupture in LMs and leakage of cellular content and cell debris may trigger airway inflammation and fibrosis, which may lead to chronic airflow limitation (CAL).The aim of this study was to determine whether lysosomal membrane permeabilization (LMP) in LMs challenged to oxidants ex vivo is associated with airway inflammation and CAL, the latter assessed as the reduced forced expiratory volume in one second (FEV1) expressed as % of predicted.OBJECTIVEThe aim of this study was to determine whether lysosomal membrane permeabilization (LMP) in LMs challenged to oxidants ex vivo is associated with airway inflammation and CAL, the latter assessed as the reduced forced expiratory volume in one second (FEV1) expressed as % of predicted.Twenty-eight subjects were investigated; 13 lung-healthy subjects and 15 subjects with a variety of inflammatory disorders, demonstrating CAL on dynamic spirometry (defined as an FEV1/FVC ratio < 0.70). LMs were harvested by broncho-alveolar lavage (BAL) and challenged ex vivo by oxidants. LMP in oxidant-exposed LMs was assessed as the emitted acridine orange (AO) green fluorescence from oxidant-exposed LMs (using macrophage-like murine J774 cells as positive controls). Inflammatory cells in BAL were counted and lung volumes were recorded.MATERIALS AND METHODSTwenty-eight subjects were investigated; 13 lung-healthy subjects and 15 subjects with a variety of inflammatory disorders, demonstrating CAL on dynamic spirometry (defined as an FEV1/FVC ratio < 0.70). LMs were harvested by broncho-alveolar lavage (BAL) and challenged ex vivo by oxidants. LMP in oxidant-exposed LMs was assessed as the emitted acridine orange (AO) green fluorescence from oxidant-exposed LMs (using macrophage-like murine J774 cells as positive controls). Inflammatory cells in BAL were counted and lung volumes were recorded.Oxidant-induced LMP in LMs was significantly greater among subjects with CAL and particularly among those with ongoing inflammation. Previous tobacco history did not influence LMP. Among subjects with CAL, oxidant-induced LMP correlated negatively with FEV1% of predicted.RESULTSOxidant-induced LMP in LMs was significantly greater among subjects with CAL and particularly among those with ongoing inflammation. Previous tobacco history did not influence LMP. Among subjects with CAL, oxidant-induced LMP correlated negatively with FEV1% of predicted.Lysosomes of LMs harvested from patients with CAL demonstrate an increased sensitivity to oxidants, which may trigger mechanisms behind CAL, eg, chronic airway inflammation and fibrotic re-modelling. The study suggests a mechanistic role for LMP in LMs on airway inflammation, suggesting an anti-inflammatory effect by drugs that prevent increased LMP.CONCLUSIONLysosomes of LMs harvested from patients with CAL demonstrate an increased sensitivity to oxidants, which may trigger mechanisms behind CAL, eg, chronic airway inflammation and fibrotic re-modelling. The study suggests a mechanistic role for LMP in LMs on airway inflammation, suggesting an anti-inflammatory effect by drugs that prevent increased LMP. The lung macrophage (LM) is involved in most inflammatory processes of the human lung by clearance of dying cells and by wound repair. Upon cellular stress by oxidant challenge in vivo lysosomes may rupture in LMs and leakage of cellular content and cell debris may trigger airway inflammation and fibrosis, which may lead to chronic airflow limitation (CAL). The aim of this study was to determine whether lysosomal membrane permeabilization (LMP) in LMs challenged to oxidants ex vivo is associated with airway inflammation and CAL, the latter assessed as the reduced forced expiratory volume in one second (FEV ) expressed as % of predicted. Twenty-eight subjects were investigated; 13 lung-healthy subjects and 15 subjects with a variety of inflammatory disorders, demonstrating CAL on dynamic spirometry (defined as an FEV /FVC ratio < 0.70). LMs were harvested by broncho-alveolar lavage (BAL) and challenged ex vivo by oxidants. LMP in oxidant-exposed LMs was assessed as the emitted acridine orange (AO) green fluorescence from oxidant-exposed LMs (using macrophage-like murine J774 cells as positive controls). Inflammatory cells in BAL were counted and lung volumes were recorded. Oxidant-induced LMP in LMs was significantly greater among subjects with CAL and particularly among those with ongoing inflammation. Previous tobacco history did not influence LMP. Among subjects with CAL, oxidant-induced LMP correlated negatively with FEV % of predicted. Lysosomes of LMs harvested from patients with CAL demonstrate an increased sensitivity to oxidants, which may trigger mechanisms behind CAL, eg, chronic airway inflammation and fibrotic re-modelling. The study suggests a mechanistic role for LMP in LMs on airway inflammation, suggesting an anti-inflammatory effect by drugs that prevent increased LMP. Background: The lung macrophage (LM) is involved in most inflammatory processes of the human lung by clearance of dying cells and by wound repair. Upon cellular stress by oxidant challenge in vivo lysosomes may rupture in LMs and leakage of cellular content and cell debris may trigger airway inflammation and fibrosis, which may lead to chronic airflow limitation (CAL). Objective: The aim of this study was to determine whether lysosomal membrane permeabilization (LMP) in LMs challenged to oxidants ex vivo is associated with airway inflammation and CAL, the latter assessed as the reduced forced expiratory volume in one second (FEV1) expressed as % of predicted. Materials and Methods: Twenty-eight subjects were investigated; 13 lung-healthy subjects and 15 subjects with a variety of inflammatory disorders, demonstrating CAL on dynamic spirometry (defined as an FEV1/FVC ratio &lt; 0.70). LMs were harvested by broncho-alveolar lavage (BAL) and challenged ex vivo by oxidants. LMP in oxidant-exposed LMs was assessed as the emitted acridine orange (AO) green fluorescence from oxidant-exposed LMs (using macrophage-like murine J774 cells as positive controls). Inflammatory cells in BAL were counted and lung volumes were recorded. Results: Oxidant-induced LMP in LMs was significantly greater among subjects with CAL and particularly among those with ongoing inflammation. Previous tobacco history did not influence LMP. Among subjects with CAL, oxidant-induced LMP correlated negatively with FEV1 % of predicted. Conclusion: Lysosomes of LMs harvested from patients with CAL demonstrate an increased sensitivity to oxidants, which may trigger mechanisms behind CAL, eg, chronic airway inflammation and fibrotic re-modelling. The study suggests a mechanistic role for LMP in LMs on airway inflammation, suggesting an anti-inflammatory effect by drugs that prevent increased LMP. Background: The lung macrophage (LM) is involved in most inflammatory processes of the human lung by clearance of dying cells and by wound repair. Upon cellular stress by oxidant challenge in vivo lysosomes may rupture in LMs and leakage of cellular content and cell debris may trigger airway inflammation and fibrosis, which may lead to chronic airflow limitation (CAL). Objective: The aim of this study was to determine whether lysosomal membrane permeabilization (LMP) in LMs challenged to oxidants ex vivo is associated with airway inflammation and CAL, the latter assessed as the reduced forced expiratory volume in one second (FEVi) expressed as % of predicted. Materials and Methods: Twenty-eight subjects were investigated; 13 lung-healthy subjects and 15 subjects with a variety of inflammatory disorders, demonstrating CAL on dynamic spirometry (defined as an FE[V.sub.1]/FVC ratio < 0.70). LMs were harvested by broncho-alveolar lavage (BAL) and challenged ex vivo by oxidants. LMP in oxidant-exposed LMs was assessed as the emitted acridine orange (AO) green fluorescence from oxidant-exposed LMs (using macrophage-like murine J774 cells as positive controls). Inflammatory cells in BAL were counted and lung volumes were recorded. Results: Oxidant-induced LMP in LMs was significantly greater among subjects with CAL and particularly among those with ongoing inflammation. Previous tobacco history did not influence LMP. Among subjects with CAL, oxidant-induced LMP correlated negatively with FE[V.sub.1]% of predicted. Conclusion: Lysosomes of LMs harvested from patients with CAL demonstrate an increased sensitivity to oxidants, which may trigger mechanisms behind CAL, eg, chronic airway inflammation and fibrotic re-modelling. The study suggests a mechanistic role for LMP in LMs on airway inflammation, suggesting an anti-inflammatory effect by drugs that prevent increased LMP. Keywords: acridine orange, lung macrophages, BAL, COPD, LMP, pulmonary fibrosis Hans Lennart Persson,1,2 Apostolos Sioutas,1,2 Petra Jacobson,1,2 Linda K Vainikka3,4 1Department of Respiratory Medicine in Linköping, Linköping University, Linköping, Sweden; 2Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden; 3Department of Experimental Pathology, Linköping University, Linköping, Sweden; 4Department of Biomedical and Clinical Sciences, Linköping University, Linköping, SwedenCorrespondence: Hans Lennart PerssonDepartment of Respiratory Medicine in Linköping, Linköping University, Linköping SE-581 85, SwedenTel +46 010 1033621Email lennart.persson@liu.seBackground: The lung macrophage (LM) is involved in most inflammatory processes of the human lung by clearance of dying cells and by wound repair. Upon cellular stress by oxidant challenge in vivo lysosomes may rupture in LMs and leakage of cellular content and cell debris may trigger airway inflammation and fibrosis, which may lead to chronic airflow limitation (CAL).Objective: The aim of this study was to determine whether lysosomal membrane permeabilization (LMP) in LMs challenged to oxidants ex vivo is associated with airway inflammation and CAL, the latter assessed as the reduced forced expiratory volume in one second (FEV1) expressed as % of predicted.Materials and Methods: Twenty-eight subjects were investigated; 13 lung-healthy subjects and 15 subjects with a variety of inflammatory disorders, demonstrating CAL on dynamic spirometry (defined as an FEV1/FVC ratio < 0.70). LMs were harvested by broncho-alveolar lavage (BAL) and challenged ex vivo by oxidants. LMP in oxidant-exposed LMs was assessed as the emitted acridine orange (AO) green fluorescence from oxidant-exposed LMs (using macrophage-like murine J774 cells as positive controls). Inflammatory cells in BAL were counted and lung volumes were recorded.Results: Oxidant-induced LMP in LMs was significantly greater among subjects with CAL and particularly among those with ongoing inflammation. Previous tobacco history did not influence LMP. Among subjects with CAL, oxidant-induced LMP correlated negatively with FEV1% of predicted.Conclusion: Lysosomes of LMs harvested from patients with CAL demonstrate an increased sensitivity to oxidants, which may trigger mechanisms behind CAL, eg, chronic airway inflammation and fibrotic re-modelling. The study suggests a mechanistic role for LMP in LMs on airway inflammation, suggesting an anti-inflammatory effect by drugs that prevent increased LMP.Keywords: acridine orange, lung macrophages, BAL, COPD, LMP, pulmonary fibrosis Background: The lung macrophage (LM) is involved in most inflammatory processes of the human lung by clearance of dying cells and by wound repair. Upon cellular stress by oxidant challenge in vivo lysosomes may rupture in LMs and leakage of cellular content and cell debris may trigger airway inflammation and fibrosis, which may lead to chronic airflow limitation (CAL). Objective: The aim of this study was to determine whether lysosomal membrane permeabilization (LMP) in LMs challenged to oxidants ex vivo is associated with airway inflammation and CAL, the latter assessed as the reduced forced expiratory volume in one second (FEV1) expressed as % of predicted. Materials and Methods: Twenty-eight subjects were investigated; 13 lung-healthy subjects and 15 subjects with a variety of inflammatory disorders, demonstrating CAL on dynamic spirometry (defined as an FEV1/FVC ratio < 0.70). LMs were harvested by broncho-alveolar lavage (BAL) and challenged ex vivo by oxidants. LMP in oxidant-exposed LMs was assessed as the emitted acridine orange (AO) green fluorescence from oxidant-exposed LMs (using macrophage-like murine J774 cells as positive controls). Inflammatory cells in BAL were counted and lung volumes were recorded. Results: Oxidant-induced LMP in LMs was significantly greater among subjects with CAL and particularly among those with ongoing inflammation. Previous tobacco history did not influence LMP. Among subjects with CAL, oxidant-induced LMP correlated negatively with FEV1% of predicted. Conclusion: Lysosomes of LMs harvested from patients with CAL demonstrate an increased sensitivity to oxidants, which may trigger mechanisms behind CAL, eg, chronic airway inflammation and fibrotic re-modelling. The study suggests a mechanistic role for LMP in LMs on airway inflammation, suggesting an anti-inflammatory effect by drugs that prevent increased LMP. |
Audience | Academic |
Author | Persson, Hans Lennart Vainikka, Linda K Jacobson, Petra Sioutas, Apostolos |
Author_xml | – sequence: 1 givenname: Hans Lennart orcidid: 0000-0002-5700-7284 surname: Persson fullname: Persson, Hans Lennart – sequence: 2 givenname: Apostolos surname: Sioutas fullname: Sioutas, Apostolos – sequence: 3 givenname: Petra surname: Jacobson fullname: Jacobson, Petra – sequence: 4 givenname: Linda K orcidid: 0000-0002-4371-1238 surname: Vainikka fullname: Vainikka, Linda K |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33235481$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-171981$$DView record from Swedish Publication Index |
BookMark | eNptk11v0zAUhiM0xMbYFffIEhJCQh124sQ2F0hV-VhRp0kMuLVOHbv15NglTrqNH8LvxVnL1E5LLmL5POc98fF7nmcHPnidZS8JPs0JZe-_Tb-fXuYcUyKeZEeEMD5iuCAHO-vD7CTGKzw8DNOcPssOiyIvSsrJUfb3rG_Ao1nvF-gcVBtWS1joiCZLcE77ha5RF9DFja3BdxHpG7S26_ABzW5jiKEBh851M2_Ba3SpfbSd_QOdDR7ZiMYxBmWhSxrXtluiqTcOmmYTB1-nIm3wVqGxbY0L12hmG9vdhV9kTw24qE-23-Ps55fPPyZno9nF1-lkPBupipBuxECI2sxrUiiOhTBzQTkuSoFLXVFTzY0wgI0oqlIBq0yZV5zXqtA0rwhUuCyOs-lGtw5wJVetbaC9lQGsvNsI7UJC21nltKwrmuesgNRSoJoXwBXjYAibU8J1TpPWaKMVr_Wqn--pfbK_xndqzvaSMCI4SfzHDZ_gRtdK-64Ft5e2H_F2KRdhLVnFOM9xEni7FWjD717HTjY2Ku1cuo3QR5nTKtkip3io9foBehX61qfWDhQWrKJih1pAOrD1JqS6ahCV44qWXNCyGM55-giV3lo3ViV7Gpv29xLe7CQsNbhuGYPrh4uO--Cr3Y7ct-K_XRPwbgMko8bYanOPECyHeZBpHuR2HhJNHtBqa6_0w9Y9mvMP4IYMIA |
CitedBy_id | crossref_primary_10_3390_mps6040072 crossref_primary_10_2147_JIR_S366204 crossref_primary_10_1016_j_jid_2023_01_036 crossref_primary_10_3390_md22120561 crossref_primary_10_1128_spectrum_00995_23 crossref_primary_10_2147_COPD_S425592 |
Cites_doi | 10.1186/s12931-020-01381-5 10.1016/j.imbio.2017.11.001 10.1016/0005-2736(91)90238-4 10.1177/1753466619890538 10.1007/s00281-016-0555-3 10.1186/s12931-017-0695-6 10.2147/JIR.S128292 10.1016/j.freeradbiomed.2018.07.024 10.1186/s12931-017-0699-2 10.3390/jcm6020021 10.1016/j.toxlet.2005.05.002 10.1183/09031936.00044108 10.3389/fimmu.2018.01777 10.1164/rccm.201202-0320ST 10.1016/S0891-5849(03)00109-6 10.1089/ars.2012.4785 10.12688/f1000research.11236.2 10.21037/jtd.2019.10.43 10.1517/13543784.14.8.997 10.1186/s12931-018-0756-5 10.1378/chest.10-0818 10.4137/JCD.S13271 10.1186/1465-9921-13-83 10.14814/phy2.13584 10.1152/ajplung.00518.2016 10.1042/0264-6021:3560549 10.1093/toxsci/kfy309 10.2147/COPD.S233506 10.1136/thoraxjnl-2012-201761 10.2147/COPD.S81032 |
ContentType | Journal Article |
Copyright | 2020 Persson et al. COPYRIGHT 2020 Dove Medical Press Limited 2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2020 Persson et al. 2020 Persson et al. |
Copyright_xml | – notice: 2020 Persson et al. – notice: COPYRIGHT 2020 Dove Medical Press Limited – notice: 2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2020 Persson et al. 2020 Persson et al. |
DBID | AAYXX CITATION NPM 3V. 7RV 7XB 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH HCIFZ KB0 LK8 M2O M7P MBDVC NAPCQ PHGZM PHGZT PIMPY PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM ABXSW ADTPV AOWAS D8T DG8 ZZAVC DOA |
DOI | 10.2147/JIR.S280419 |
DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Nursing & Allied Health Database ProQuest Central (purchase pre-March 2016) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library SciTech Premium Collection Nursing & Allied Health Database (Alumni Edition) ProQuest Biological Science Collection Research Library Biological Science Database Research Library (Corporate) Nursing & Allied Health Premium ProQuest One Academic ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) SWEPUB Linköpings universitet full text SwePub SwePub Articles SWEPUB Freely available online SWEPUB Linköpings universitet SwePub Articles full text DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences Health Research Premium Collection Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Research Library ProQuest Central (New) ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Persson et al |
EISSN | 1178-7031 |
EndPage | 932 |
ExternalDocumentID | oai_doaj_org_article_d642273a703a4e83a8c78af17b418e24 oai_DiVA_org_liu_171981 PMC7678820 A645894534 33235481 10_2147_JIR_S280419 |
Genre | Journal Article |
GeographicLocations | Sweden United Kingdom--UK |
GeographicLocations_xml | – name: Sweden – name: United Kingdom--UK |
GroupedDBID | --- 0YH 29K 2WC 53G 5VS 7RV 8FE 8FH 8FI 8FJ 8G5 AAYXX ABUWG ADBBV ADRAZ AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BKEYQ BPHCQ BVXVI CCPQU CITATION D-I DIK DWQXO E3Z EBD F5P FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 HCIFZ HYE IAO IHR IHW IPNFZ ITC KQ8 LK8 M2O M48 M7P M~E NAPCQ OK1 P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC RIG RNS RPM TDBHL TR2 UKHRP VDV NPM PMFND 3V. 7XB 8FK MBDVC PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U 7X8 PUEGO 5PM ABXSW ADTPV AOWAS D8T DG8 ZZAVC |
ID | FETCH-LOGICAL-c611t-7a99dfbd13c8099fb948035905e64f6bf9fa0f9365ca76f52688dc3e4261a6053 |
IEDL.DBID | M48 |
ISSN | 1178-7031 |
IngestDate | Wed Aug 27 01:14:15 EDT 2025 Tue Sep 09 23:43:18 EDT 2025 Thu Aug 21 13:52:32 EDT 2025 Thu Sep 04 23:53:21 EDT 2025 Fri Jul 25 11:55:38 EDT 2025 Tue Jun 17 21:12:07 EDT 2025 Tue Jun 10 20:16:07 EDT 2025 Thu May 22 21:06:37 EDT 2025 Thu Jan 02 22:54:15 EST 2025 Tue Jul 01 03:13:47 EDT 2025 Thu Apr 24 23:04:15 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | BAL LMP acridine orange lung macrophages pulmonary fibrosis COPD |
Language | English |
License | http://creativecommons.org/licenses/by-nc/3.0 2020 Persson et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c611t-7a99dfbd13c8099fb948035905e64f6bf9fa0f9365ca76f52688dc3e4261a6053 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-5700-7284 0000-0002-4371-1238 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.2147/JIR.S280419 |
PMID | 33235481 |
PQID | 2460976491 |
PQPubID | 3933408 |
PageCount | 8 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_d642273a703a4e83a8c78af17b418e24 swepub_primary_oai_DiVA_org_liu_171981 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7678820 proquest_miscellaneous_2464192401 proquest_journals_2460976491 gale_infotracmisc_A645894534 gale_infotracacademiconefile_A645894534 gale_healthsolutions_A645894534 pubmed_primary_33235481 crossref_primary_10_2147_JIR_S280419 crossref_citationtrail_10_2147_JIR_S280419 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-01-01 |
PublicationDateYYYYMMDD | 2020-01-01 |
PublicationDate_xml | – month: 01 year: 2020 text: 2020-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | New Zealand |
PublicationPlace_xml | – name: New Zealand – name: Macclesfield |
PublicationTitle | Journal of inflammation research |
PublicationTitleAlternate | J Inflamm Res |
PublicationYear | 2020 |
Publisher | Dove Medical Press Limited Taylor & Francis Ltd Dove Dove Medical Press |
Publisher_xml | – name: Dove Medical Press Limited – name: Taylor & Francis Ltd – name: Dove – name: Dove Medical Press |
References | Yu (ref26) 2003; 34 Yang (ref4) 2018; 19 Liao (ref8) 2019; 13 Persson (ref12) 2013; 6 Laskin (ref22) 2019; 168 Brown (ref2) 2020; 21 Wang (ref24) 2020; 15 Grabiec (ref19) 2016; 38 Fan (ref23) 2018; 19 Arora (ref21) 2018; 223 Weidner (ref5) 2018; 6 Aja (ref6) 2017; 6 Persson (ref28) 2011; 139 Persson (ref27) 2009; 33 Yang (ref3) 2018; 19 Persson (ref9) 2005; 14 Sioutas (ref13) 2017; 10 Milara (ref14) 2013; 68 Mahmood (ref15) 2015; 10 Hikichi (ref1) 2019; 11 Meyer (ref18) 2012; 185 Hodge (ref25) 2017; 312 Persson (ref11) 2012; 13 Zhang (ref7) 2019; 133 Mattsson (ref17) 1991; 1065 Brüne (ref30) 2013; 19 Kota (ref16) 2017; 6 Antunes (ref29) 2001; 356 Persson (ref10) 2005; 159 Allard (ref20) 2018; 9 |
References_xml | – volume: 21 start-page: 111 year: 2020 ident: ref2 publication-title: Respir Res doi: 10.1186/s12931-020-01381-5 – volume: 223 start-page: 383 year: 2018 ident: ref21 publication-title: Immunobiology doi: 10.1016/j.imbio.2017.11.001 – volume: 1065 start-page: 261 year: 1991 ident: ref17 publication-title: Biochim Biophys Acta doi: 10.1016/0005-2736(91)90238-4 – volume: 13 start-page: 1753466619890538 year: 2019 ident: ref8 publication-title: Ther Adv Respir Dis doi: 10.1177/1753466619890538 – volume: 38 start-page: 409 year: 2016 ident: ref19 publication-title: Semin Immunopathol doi: 10.1007/s00281-016-0555-3 – volume: 19 start-page: 40 year: 2018 ident: ref3 publication-title: Respir Res doi: 10.1186/s12931-017-0695-6 – volume: 10 start-page: 29 year: 2017 ident: ref13 publication-title: J Inflamm Res doi: 10.2147/JIR.S128292 – volume: 133 start-page: 238 year: 2019 ident: ref7 publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2018.07.024 – volume: 19 start-page: 39 year: 2018 ident: ref4 publication-title: Respir Res doi: 10.1186/s12931-017-0699-2 – volume: 6 start-page: 21 year: 2017 ident: ref6 publication-title: J Clin Med doi: 10.3390/jcm6020021 – volume: 159 start-page: 124 year: 2005 ident: ref10 publication-title: Toxicol Lett doi: 10.1016/j.toxlet.2005.05.002 – volume: 33 start-page: 673 year: 2009 ident: ref27 publication-title: Eur Respir J doi: 10.1183/09031936.00044108 – volume: 9 start-page: 1777 year: 2018 ident: ref20 publication-title: Front Immunol doi: 10.3389/fimmu.2018.01777 – volume: 185 start-page: 1004 year: 2012 ident: ref18 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201202-0320ST – volume: 34 start-page: 1243 year: 2003 ident: ref26 publication-title: Free Radic Biol Med doi: 10.1016/S0891-5849(03)00109-6 – volume: 19 start-page: 595 year: 2013 ident: ref30 publication-title: Antioxid Redox Signal doi: 10.1089/ars.2012.4785 – volume: 6 start-page: 409 year: 2017 ident: ref16 publication-title: Res doi: 10.12688/f1000research.11236.2 – volume: 11 start-page: S2129 year: 2019 ident: ref1 publication-title: J Thorac Dis doi: 10.21037/jtd.2019.10.43 – volume: 14 start-page: 997 year: 2005 ident: ref9 publication-title: Expert Opin Investig Drugs doi: 10.1517/13543784.14.8.997 – volume: 19 start-page: 50 year: 2018 ident: ref23 publication-title: Respir Res doi: 10.1186/s12931-018-0756-5 – volume: 139 start-page: 361 year: 2011 ident: ref28 publication-title: Chest doi: 10.1378/chest.10-0818 – volume: 6 start-page: 69 year: 2013 ident: ref12 publication-title: J Cell Death doi: 10.4137/JCD.S13271 – volume: 13 start-page: 83 year: 2012 ident: ref11 publication-title: Respir Res doi: 10.1186/1465-9921-13-83 – volume: 6 start-page: e13584 year: 2018 ident: ref5 publication-title: Physiol Rep doi: 10.14814/phy2.13584 – volume: 312 start-page: L678 year: 2017 ident: ref25 publication-title: Am J Physiol Lung Cell Mol Physiol doi: 10.1152/ajplung.00518.2016 – volume: 356 start-page: 549 year: 2001 ident: ref29 publication-title: Biochem J doi: 10.1042/0264-6021:3560549 – volume: 168 start-page: 287 year: 2019 ident: ref22 publication-title: Toxicol Sci doi: 10.1093/toxsci/kfy309 – volume: 15 start-page: 1093 year: 2020 ident: ref24 publication-title: Int J Chron Obstruct Pulmon Dis doi: 10.2147/COPD.S233506 – volume: 68 start-page: 410 year: 2013 ident: ref14 publication-title: Thorax doi: 10.1136/thoraxjnl-2012-201761 – volume: 10 start-page: 1515 year: 2015 ident: ref15 publication-title: Int J Chron Obstruct Pulmon Dis doi: 10.2147/COPD.S81032 |
SSID | ssj0000070424 |
Score | 2.1763155 |
Snippet | The lung macrophage (LM) is involved in most inflammatory processes of the human lung by clearance of dying cells and by wound repair. Upon cellular stress by... Background: The lung macrophage (LM) is involved in most inflammatory processes of the human lung by clearance of dying cells and by wound repair. Upon... Hans Lennart Persson,1,2 Apostolos Sioutas,1,2 Petra Jacobson,1,2 Linda K Vainikka3,4 1Department of Respiratory Medicine in Linköping, Linköping University,... |
SourceID | doaj swepub pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 925 |
SubjectTerms | Acridine orange Alveoli Asthma Autophagy bal Bronchoscopy Cellular stress response Chronic obstructive pulmonary disease copd Experiments Fibroblasts Fibrosis Fluorescence Inflammation Inflammatory diseases lmp Lung diseases Lung diseases, Obstructive lung macrophages Lungs Lysosomes Macrophages Original Research Oxidants Oxidative stress pulmonary fibrosis Respiratory tract Respiratory tract diseases Sarcoidosis Smoking Spirometry Tobacco Wound healing |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gL4s2WFoxUgYQUuo7zsLkthaqtuiBRinqzHMdWI22TqsmW8kf4vczY2WgDSFy4xmMr9ow9M_bMN4TsFE5wx6Y2YrE2EWg8ERWg5yKuRQoKyDlpfYDsp-zgNDk6S8_WSn1hTFiABw4Lt1uCgQwqVoNk6sQKGMPkQjuWFwkTNvZIoKDG1pypYPjm-KYXKquICEHaQ3IeluXZPTr88vYkRuQdOVJHHrX_z7N5TTn9Hjg5ghf1Kmn_Hrnb25J0FuZwn9yy9QNye96_lj8kP_0NPT2G_UznGmt1ncPp0dK9VQGVknYN_XxTlRgMQ-0Nva6um3f0-EfbtM0FDD23F-BN15aeYJx71-ds0qqlK7bCGHiVSw9rB7IV8iCprkvao-7SWXXlFs136jOpfPMjcrr_8eveQdTXYYhMxlgX5VrK0hUl40aAQekKmQhE_pumNktcVjjp9NRJnqVG55lDABlRGm7RO9PgLvHHZKNuavuU0NJaETsmNfidSZ4VQpiSpzpndmoKw9mEvFmxQ5n-r7BWxkKBs4K8U8A71fNuQnYG4suAzfF3svfI14EEAbX9BxAz1YuZ-peYTcgLlAoVslOHY0HNsiQVMkk5ULz2FHgwwC8b3ec3wMQRYmtEuTWihA1txs0ryVP9gdKqOMmmYDkmEpbo5dCMPTFIrrbN0tPgmz54zBPyJAjqMGnOYw7OKbTkIxEercq4pa7OPdx4DvYM2IkT8ioI-6jLh-rbzC_koloqljMp2Ob_WO9n5E6MNxv-smuLbHRXS7sN5l9XPPc7_ReydFbe priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ta9RAEF7qFcQv4rvRqisUBSH2NrtJNoLItba0pVeltdJvYbPZtYFrUu-l1j_i73VmszmNil-zk5BkZudtZ54hZL2wkls2NCGLlA7B4smwADsXciVjMEDWZsYVyB4muydi_zQ-XSGHXS8MllV2OtEp6rLRmCPfiEQyBNMpMvbu4muIU6PwdLUboaH8aIXyrYMYu0ZWI5yqPCCrm9uHH4-WWRdEtxGRaBv1cETPxv7e0evjCFF4sp5pcgj-f-vp3wzVn0WUPahRZ552bpGb3q-ko1YQbpMVU98h18f-5Pwu-eGy9fQA9jYdK5zbdQaaZEa3umEqJZ039MNVVWJhDDVX9LK6bN7Qg--zZtacw6PH5hwi69rQY6x5n_v-TVrNaMdieAamdelebUHO2p5IquqSegReOqqmdtJ8o66ryi3fIyc725-2dkM_kyHUCWPzMFVZVtqiZFxLcC5tkQmJKIDD2CTCJoXNrBrajCexVmliEUxGlpobjNQUhE78PhnUTW0eEloaIyPLMgUxqEiTQkpd8lilzAx1oTkLyKuOHbn2b4VzMyY5BC7Iuxx4l3veBWR9SXzR4nT8m2wT-bokQXBtd6GZfsn9Xs1LiMnAq1OgDJUwEsRWp1JZlhaCSROJgDxDqcjbTtWlishHiYhlJmIOFC8dBSoJeGWtfK8DfDjCbfUo13qUsLl1f7mTvNwrl1n-aysE5PlyGe_EgrnaNAtHg-f7ED0H5EErqMuP5jziEKjCStoT4d5f6a_U1ZmDHk_BtwGfMSAvWmHv3fK--jxyP3JSLXKWskyyR_9__8fkRoT5C5fSWiOD-XRhnoCTNy-e-p37E38jU9I priority: 102 providerName: ProQuest |
Title | Human Lung Macrophages Challenged to Oxidants ex vivo: Lysosomal Membrane Sensitization is Associated with Inflammation and Chronic Airflow Limitation |
URI | https://www.ncbi.nlm.nih.gov/pubmed/33235481 https://www.proquest.com/docview/2460976491 https://www.proquest.com/docview/2464192401 https://pubmed.ncbi.nlm.nih.gov/PMC7678820 https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-171981 https://doaj.org/article/d642273a703a4e83a8c78af17b418e24 |
Volume | 13 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1178-7031 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000070424 issn: 1178-7031 databaseCode: KQ8 dateStart: 20080101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1178-7031 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000070424 issn: 1178-7031 databaseCode: DOA dateStart: 20080101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1178-7031 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000070424 issn: 1178-7031 databaseCode: DIK dateStart: 20080101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1178-7031 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000070424 issn: 1178-7031 databaseCode: GX1 dateStart: 20080101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1178-7031 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000070424 issn: 1178-7031 databaseCode: M~E dateStart: 20080101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1178-7031 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000070424 issn: 1178-7031 databaseCode: RPM dateStart: 20080101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1178-7031 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000070424 issn: 1178-7031 databaseCode: BENPR dateStart: 20080101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 1178-7031 dateEnd: 20250131 omitProxy: true ssIdentifier: ssj0000070424 issn: 1178-7031 databaseCode: M48 dateStart: 20080901 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal – providerCode: PRVAWR databaseName: Taylor & Francis Open Access customDbUrl: eissn: 1178-7031 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000070424 issn: 1178-7031 databaseCode: 0YH dateStart: 20080901 isFulltext: true titleUrlDefault: https://www.tandfonline.com providerName: Taylor & Francis |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3db9MwELfGJiFeEN90G8VIE0hIGXXsJA4SQt3Y2KZ1oI1OfYscx2aRugT6Mbp_hL-XOyepyJjESx_qc5T4fue7s--DkK3USm5Zz3jMV9oDjSe9FPScx5UMQAFZGxsXIHsSHgzF0SgYrZCmGWe9gNNbXTvsJzWcjLcXP68_gsB_wDBmJqJ3R4en22c-FtKJ75A1UEk-wntQ2_mVHRzhFV_VaEV6WLO9ytW7Ob-lnVwR_3-36r901c04yla1Uaeh9h-Q-7VpSfsVFh6SFVM8IncH9eX5Y_LbHdjTYxBvOlDYuusCNpMp3W36qWR0VtIvizzD2BhqFvQqvyrf0-PraTktL-HRA3MJznVh6BmGvc_qFE6aT2nDZXgGnuzSw8IC1Kq0SKqKjNZFeGk_n9hx-Yu6xCo3_IQM9_e-7R54dVsGT4eMzbxIxXFm04xxLcG-tGksJBYC7AUmFDZMbWxVz8Y8DLSKQov1ZGSmuUFnTYH3xJ-S1aIszHNCM2Okb1mswA0VUZhKqTMeqIiZnk41Zx3ytmFHouu3wtYZ4wR8F-RdArxLat51yNaS-EdVquN2sh3k65IE62u7P8rJ96QW1yQDtwwMOwVIUcJIQK6OpLIsSgWTxhcd8hJRkVTJqstdIumHIpCxCDhQvHEUiFx4Za3qdAf4cKy41aLcbFGCfOv2cIO8pBGPxBdhDwxJEcMSvVoO40yMmStMOXc0eMUPDnSHPKuAuvxozn0OviqMRC0It1alPVLkF676eATmDZiNHfK6Antryqf8vO8WcpzPExaxWLL1_y7VBrnn4ymGO9jaJKuzydy8AFNvlnbJ2s7eydfTrjsqgd_PI9Z1ov0HWmZVrQ |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9QwELZKKwEviJuFQo1UQEIKXcdO4iBVaHtpt91dUA_Ut-A4No20TcoePf4IP4ffxthxFgKIt77GE8vJjOewZ75BaDXVnGrSVh7xhfTA4nEvBTvnUcEDMEBax8omyA7D7hHbPQ6OF9CPuhbGpFXWOtEq6qyU5ox8zWdhG0wni8mHs2-e6RplblfrFhrCtVbI1i3EmCvs2FNXFxDCTdZ7W8DvV76_s3242fVclwFPhoRMvUjEcabTjFDJwV3Sacy4wbVrBypkOkx1rEVbxzQMpIhCbeBReCapMrGHgGCAwrw30BK4HRR21dLG9vDT_vyUx6DpMJ9VhYGmJdDabm__3YFvUH_ihim0HQP-tgu_GcY_kzYb0KbWHO7cRXecH4s7leDdQwuquI9uDtxN_QP03d4O4D7oEjwQpk_YCWiuCd6sm7dkeFrij5d5ZhJxsLrE5_l5-R73ryblpDyFqQfqFCL5QuEDk2M_dfWiOJ_gWqRgDnOMjHuFBrmuajCxKDLsEH9xJx_rUXmBbRWXHX6Ijq6FO4_QYlEW6gnCmVLc1yQWEPOyKEw5lxkNRERUW6aSkhZ6W7MjkW5Vpk_HKIFAyfAuAd4ljncttDonPqtwQf5NtmH4OicxYN72QTn-mjjdkGQQA4IXKUD5CqY4bBMZcaFJlDLClc9aaMVIRVJVxs5VUtIJWcBjFlCgeGMpjFKCJUvhaivgww28V4NyuUEJykQ2h2vJS5wymyS_tl4LvZwPmzdNgl6hypmlMfkEEK230ONKUOcfTalPITCGkaghwo2_0hwp8hMLdR6BLwU-agu9roS98cpW_rljf-QonyUkIjEnT_-__hV0q3s46Cf93nDvGbrtm7MTe5y2jBan45l6Dg7mNH3hdjFGX65bcfwEKRaQAw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtQwELVKK1W8IO4sFGqkAhJS2HXiJA5ShbbdVt3eqFqK-hYcx6aR2qTsbm8_wkfxVcw4zkIA8dbXeGI5mfGZGXsuhCxlRgSG9bTHfKk80HjCy0DPeYEUISggYxJtA2R3o41DvnkUHs2QH00uDIZVNphogTqvFJ6Rd30e9UB18oR1jQuL2Busfzj75mEHKbxpbdppSNdmIV-25cZckseWvr4Ed268PBwA71_5_vrap9UNz3Uc8FTE2MSLZZLkJstZoASYTiZLuMAad71QR9xEmUmM7JkkiEIl48hgqRSRq0CjHyLBMQhg3ltkLsZ80Vkyt7K2u7c_PfHByjrc53WSILYH6m4O998d-FgBKGmpRds94G8d8ZuS_DOAs1Xm1KrG9bvkjrNpab8WwntkRpf3yfyOu7V_QL7bmwK6DbhCdyT2DDsGFBvT1aaRS04nFf14VeQYlEP1Fb0oLqr3dPt6XI2rU5h6R5-CV19qeoDx9hOXO0qLMW3EC-bAI2U6LA3IeJ2PSWWZU1f9l_aLkTmpLqnN6LLDD8nhjXDnEZktq1I_ITTXWviGJRL8Xx5HmRAqD0IZM91TmQpYh7xt2JEqtyrs2XGSgtOEvEuBd6njXYcsTYnP6hoh_yZbQb5OSbCwt31Qjb6mDifSHPxBsCglALHkWsCWUbGQhsUZZ0L7vEMWUSrSOkt2Ck9pP-KhSHgYAMUbS4EABUtW0uVZwIdjqa8W5UKLEoBFtYcbyUsdsI3TX9uwQ15Oh_FNDNYrdXVuaTC2ADz3DnlcC-r0o4PAD8BJhpG4JcKtv9IeKYtjW_Y8BrsK7NUOeV0Le-uVQfG5b3_kSXGespglgj39__oXyTwASLo93N16Rm77eIxiT9YWyOxkdK6fg605yV64TUzJl5vGjZ_uK5Q9 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Human+Lung+Macrophages+Challenged+to+Oxidants+ex+vivo%3A+Lysosomal+Membrane+Sensitization+is+Associated+with+Inflammation+and+Chronic+Airflow+Limitation&rft.jtitle=Journal+of+inflammation+research&rft.au=Sioutas%2C+Apostolos&rft.au=Jacobson%2C+Petra&rft.au=Persson%2C+Hans+Lennart&rft.au=Vainikka%2C+Linda+K&rft.date=2020-01-01&rft.pub=Dove+Medical+Press+Limited&rft.issn=1178-7031&rft.eissn=1178-7031&rft.volume=13&rft.spage=925&rft_id=info:doi/10.2147%2FJIR.S280419&rft.externalDBID=n%2Fa&rft.externalDocID=A645894534 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1178-7031&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1178-7031&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1178-7031&client=summon |